Cargando…
Identification of Novel Leishmania donovani Antigens that Help Define Correlates of Vaccine-Mediated Protection in Visceral Leishmaniasis
Visceral leishmaniasis (VL), caused by the intracellular parasite Leishmania donovani is a major public health problem in the developing world. But there is no effective and safe vaccine approved for clinical use against any form of leishmaniasis. Through reactivity with kala-azar patient and cured...
Autores principales: | Bhowmick, Sudipta, Ali, Nahid |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686101/ https://www.ncbi.nlm.nih.gov/pubmed/19503834 http://dx.doi.org/10.1371/journal.pone.0005820 |
Ejemplares similares
-
Investigation of the antigenicity and protective efficacy of Leishmania promastigote membrane antigens in search of potential diagnostic and vaccine candidates against visceral leishmaniasis
por: Ejazi, Sarfaraz Ahmad, et al.
Publicado: (2020) -
Identification of Leishmania donovani antigen in circulating immune complexes of visceral leishmaniasis subjects for diagnosis
por: Jamal, Fauzia, et al.
Publicado: (2017) -
Hemophagocytosis in Experimental Visceral Leishmaniasis by Leishmania donovani
por: Morimoto, Ayako, et al.
Publicado: (2016) -
IL-4 contributes to failure, and colludes with IL-10 to exacerbate Leishmania donovani infection following administration of a subcutaneous leishmanial antigen vaccine
por: Bhowmick, Sudipta, et al.
Publicado: (2014) -
Isolation and characterisation of Leishmania donovani protein antigens from urine of visceral leishmaniasis patients
por: Marlais, Tegwen, et al.
Publicado: (2020)